Echoing her boss’s op-ed last week, Centers for Medicare & Medicaid Services Administrator Seema Verma devoted an unusually long time in one speech to why a popular progressive proposal would not work.
The Trump administration wants drug companies to put their list prices in television ads, but whether that policy is something it can actually enforce remains a major question.
UnitedHealth CEO David Wichmann told investors during an earnings call on Tuesday that the company is preparing to launch a “fully individualized and fully portable” EHR to 50 million members by the end of next year. But it’s not clear how that product…
Authorities said the CEO of a pain clinic was allegedly involved in a scheme to illegally distribute opioids and used the proceeds for luxury clothes from retailers like Hermes, exotic vehicles such as the Lamborghini, a mansion and other real estate i…
Do you know an influential startup that’s flying under the radar? Tell us how they are changing the healthcare industry as we know it by Nov. 15 for consideration in our Fierce 15 awards.
The Trump administration is planning to force drug companies to include the list price of their products in direct-to-consumer advertising, as part of its ongoing efforts to bring down the cost of drugs.
The CEO of the telemedicine company HealthRight was charged alongside several compounding pharmacies for a $1 billion fraud scheme that charged insurers for marked-up pain creams and marketed millions in bogus supplements to patients.
A final rule sent to OMB on Thursday resurfaces a contentious regulation that loosened “moral exemptions” for birth control coverage under the ACA. The rule could lead to a new round of legal challenges after several courts halted last year’s rule.
Anywhere from 2.1 million to 4.9 million children and adults could discontinue their enrollment, a trend that would have countless public health and economic implications, says a new analysis from the Kaiser Family Foundation.
Senate Judiciary Committee Chairman Chuck Grassley is calling for the Federal Trade Commission to examine “potentially anticompetitive contracting practices between insurers and hospital systems” that could be driving up costs for consumers.